On February 21, a media report alleged that the company was producing unlicensed, highly addictive opioids and illegally ...

Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP (Current Good Manufacturing Practices) ...

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.

Nandita Vijayasimha, Bengaluru Thursday, April 3, 2025, 08:00 Hrs [IST] ...

This story has been updated with healthcare industry reactions and additional information released by the administration on ...

Mumbai, Mar 29: Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report. Essentially, Indian pharmaceutical companies have the ...

Shares of Milestone Pharmaceuticals Inc. (MIST) traded 60% lower on Friday after the Food and Drug Administration (FDA) did ...

Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

The US president stated that the purpose of these charges was to address decades of unfair trade practices that had hurt the ...

President Trump's tariffs aim to boost U.S. manufacturing, tackle trade deficits, and global market's reaction to economic ...

The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.